The 340B program’s new rebate pilot won’t fix its problems

The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with a major lack of transparency about how savings are used to benefit patients. As HRSA launches a new rebate-based model meant to boost oversight, experts warned that it could instead burden smaller providers and fail to address the program's deeper flaws.

Editor's Pick

Top Story The 340B Program's New Rebate Pilot Won't Fix Its Problems The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with a major lack of transparency about how savings are used to benefit patients. As HRSA launches a new rebate-based model meant to boost oversight, experts warned that it could instead burden smaller providers and fail to address the program's deeper flaws. Sponsored Turning AI Insights into Meaningful Action: The Future of Healthcare Navigation Presented by Quantum Health Chief AI Officer, Shannon Skaggs highlights how the confluence of AI and predictive analytics is rapidly transforming healthcare and benefits management and what the future holds. Read More About The Future of AI in Benefits Management

Featured News

Cigna Launches Mental Health Collaboration with Headspace Cigna Healthcare has partnered with Headspace to offer over 7 million members access to Headspace's digital mental health tools. Novel Novartis Malaria Drug Shows Promise to Become New Asset Against Resistant Strains Phase 3 results for the Novartis malaria drug "GanLum" show it was comparable to the standard of care and led to cure rates that top the threshold recommended by the World Health Organization. If approved, this new combination drug would become the first novel malaria therapy in more than 25 years. Combining Ketamine and Deep TMS: A New Frontier in Treating Depression Emerging evidence suggests that combining these interventions may enhance treatment outcomes and provide options for patients who have not responded to traditional therapies. Health Insurance Enrollment: Winning OEP With a Tech-Driven Call Center Adding more agents or buying more leads are just pieces of the puzzle, but they don't address the multifaceted challenge of open enrollment. Teams must be aligned around meaningful metrics rather than vanity measures like total dials.

Video   Video: How AI Is Tackling Administrative Burdens There is no question that EHRs have created major administrative burdens, noted Nikhil Buduma, CEO of Ambience Healthcare.  These systems are causing clinicians to spend most of their time on documentation and billing work instead of connecting with patients. Buduma said Ambience aims to solve this by integrating AI directly into EHR workflows to automate tasks before, during and after the visit. The goal is to remove non-clinical work so clinicians can focus on the patient in front of them and restore joy in practicing medicine.

Resources

Debunked Episode 21: The Drug Price Debate, AI in Healthcare Companies Face Consolidation But How Much? How many companies will be left standing once consolidation hits the AI in healthcare sector? Which pharma companies are working with the Trump administration to lower costs? View Now

MedCity News • PO Box 901 • New York, NY unsubscribe